0000000000019464

AUTHOR

Venkata Pradeep Babu Koyyala

showing 8 related works from this author

P40.04 Knowledge, Attitudes and Perception of Lung Cancer Screening Among Smoking Soft-Ware Professionals in India

2021

Pulmonary and Respiratory Medicinemedicine.medical_specialtyOncologybusiness.industryPerceptionmedia_common.quotation_subjectFamily medicinemedicinebusinessLung cancer screeningmedia_commonJournal of Thoracic Oncology
researchProduct

71P Role of radiomics in predicting molecular phenotypes of female breast cancer

2020

Oncologymedicine.medical_specialtyOncologyRadiomicsbusiness.industryInternal medicinemedicineHematologybusinessPhenotypeFemale breast cancerAnnals of Oncology
researchProduct

P-309 Correlation between baseline CEA levels and TNM stage at presentation in colorectal cancers in an Indian population

2020

OncologyCorrelationmedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineIndian populationHematologyStage (cooking)Presentation (obstetrics)businessBaseline (configuration management)Annals of Oncology
researchProduct

55P Role of radiomics for predicting immunophenotypes in male breast cancer

2020

Oncologymedicine.medical_specialtyOncologyRadiomicsbusiness.industryMale breast cancerInternal medicinemedicineHematologymedicine.diseasebusinessAnnals of Oncology
researchProduct

215P Analysis of spatial heterogeneity of responses in metastatic sites with nivolumab in renal cell carcinoma

2020

Oncologybusiness.industryRenal cell carcinomaCancer researchMedicineHematologyNivolumabbusinessmedicine.diseaseSpatial heterogeneityAnnals of Oncology
researchProduct

The war against coronavirus disease 19 through the eyes of cancer physician: An Italian and Indian young medical oncologist's perspective

2020

These are unprecedented times, we are living in with an outbreak of a novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (CoV-2), or CoV Disease 19 (COVID-19). By April 20th, as per the World Health Organization Data, COVID-19 as a pandemic has caused 2,407,414 cases, and 165,073 confirmed deaths in 213 different countries worldwide. Elderly patients and those with comorbid illnesses with COVID-19 infection have poor outcomes. Cancer patients are immunosuppressed, and at an increased risk of COVID-19 infection and have worse outcomes as compared to the general population. The mortality rate of COVID-19 among oncology patients is about 20%.[1] Young oncologists …

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Perspective (graphical)CancerDiseasemedicine.disease_causemedicine.diseaseSpanish Civil Waroncology covid-19OncologyFamily medicinePediatrics Perinatology and Child HealthmedicinebusinessCoronavirus
researchProduct

P-189 Role of radiomics in clinical prognostication and prediction of survival among a cohort of metastatic intrahepatic cholangiocarcinoma

2020

Oncologymedicine.medical_specialtyOncologyRadiomicsbusiness.industryInternal medicineCohortmedicineHematologybusinessIntrahepatic CholangiocarcinomaAnnals of Oncology
researchProduct

72P Non-mass like enhancement patterns on MR mammography and their pathological correlation

2020

medicine.medical_specialtyOncologybusiness.industryMedicineHematologyRadiologybusinessPathological correlationMr mammographyAnnals of Oncology
researchProduct